For the quarter ending 2025-09-30, BHVN had $19,387K increase in cash & cash equivalents over the period. -$145,729K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -173,443 | -419,824 |
| Depreciation and amortization | 3,125 | 4,224 |
| Non-cash share-based compensation | 21,535 | 73,874 |
| Issuance of common shares as payment for acquisition of ipr&d asset | 0 | 0 |
| Issuance of common shares as payment under license and other agreements | 0 | 4,844 |
| Fair value of forward contract and derivative liabilities under license agreement | 0 | 0 |
| Change in fair value of forward contract and derivative liabilities | 3,960 | 7,314 |
| Issuance of warrant under license agreement | 0 | 0 |
| Change in fair value of notes payable | -11,200 | -1,190 |
| Other non-cash items, net | 1,162 | 4,247 |
| Prepaid expenses and other current and non-current assets | -6,497 | 11,781 |
| Accounts payable | -2,137 | 1,599 |
| Accrued expenses and other current and non-current liabilities | -7,371 | 24,375 |
| Net cash used in operating activities | -145,716 | -333,060 |
| Proceeds from maturities of marketable securities | 165,000 | 330,000 |
| Purchases of marketable securities | 0 | 178,144 |
| Purchases of property and equipment | 13 | 694 |
| Other investing activities | 20 | 1,829 |
| Net cash provided by (used in) investing activities | 164,967 | 149,333 |
| Proceeds from issuance of notes payable | 0 | 250,000 |
| Proceeds from issuance of common shares | 0 | 0 |
| Payment of issuance costs | 0 | 1,247 |
| Proceeds from equity incentive plan | 122 | 1,446 |
| Other financing activities, net | 0 | 0 |
| Net cash provided by financing activities | 122 | 250,199 |
| Effects of exchange rates on cash, cash equivalents, and restricted cash | 14 | -17 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 19,387 | 66,455 |
| Cash and cash equivalents at beginning of period | 102,542 | - |
| Cash and cash equivalents at end of period | 188,384 | - |
Biohaven Ltd. (BHVN)
Biohaven Ltd. (BHVN)